Skip to main content
Journal of Diabetes and Metabolic Disorders logoLink to Journal of Diabetes and Metabolic Disorders
. 2022 Apr 4;21(1):455–461. doi: 10.1007/s40200-022-00995-4

Self-care practice and glycemic Control among type 2 diabetes patients on follow up in a developing country: a prospective observational study

Abinet Abebe 1,, Yohannes Wobie 1, Bezie Kebede 1, Alemnew Wale 2, Alemnew Destaw 3, Abyou Seyfu Ambaye 4
PMCID: PMC9167384  PMID: 35673465

Abstract

Purpose

The main goal of managing diabetes is to achieve glycemic control. However, the glycemic level of most diabetic patients is shown to be poorly controlled mainly due to poor adherence to self-care practices. This study aims to assess the level of self-care practice and glycemic control among type 2 diabetes patients on follow up in a resource limited country.

Methods

A four-month prospective observational study was conducted among type 2 diabetes patients from February 1 to May 30, 2021. Data was collected using a data abstraction checklist and structured questionnaire. The data was entered into Epidata version 4.4.6 and analyzed with SPSS version 26. Glycemic control and its predictors were determined using binary logistic regression. P-value less than 0.05 was considered as statistically significant.

Results

A total of 138 patients were included in the study. Nearly three-fourths (74.6%) of patients had poor glycemic control and the majority of patients had poor self-care practice. 78.3%, 98.6%, 96.4%, and 55.8% of patients had poor adherence to diet, exercise, self-monitoring of blood glucose, and medications respectively. Importantly, 85(79%), 102(75%), 99(74.4%), and 65(84.4%) patients with poor adherence to diet, physical activity, self-monitoring of blood glucose, and antidiabetic medications had poor glycemic control. On multivariate logistic regression, BMI (AOR 4.1, CI:1.20–14.11, p = 0.024) and drug adherence (AOR 3.08, CI:1.22–7.08, p = 0.017) were factors associated with poor glycemic control.

Conclusions

A higher proportion of patients had low-level of self-care practice and poor glycemic control. This highlights the need to improve patients’ awareness about the importance of self-care practice to maintain good glycemic control and prevent adverse outcomes associated with the disease.

Supplementary Information

The online version contains supplementary material available at 10.1007/s40200-022-00995-4.

Keywords: Diabetic self-care, Glycemic control, Type 2 diabetes, Ethiopia

Background

Diabetes is a major chronic global public health problem associated with mortality and morbidity. The global diabetes prevalence is estimated to be 9.3% in 2019, rising to 10.2% by 2030 [1]. There are four types of diabetes; type 1 diabetes, type 2 diabetes, gestational diabetes, and Specific types of diabetes due to other causes. Type 2 diabetes accounts for 90–95% of all diabetes [2].

The prevalence of type 2 diabetes is increasing across all regions of the world and is expected to be higher in low to middle-income countries due to aging populations, increasing urbanization, reduced physical activity, and unhealthy lifestyle and behavioral patterns [1, 3]. Type 2 diabetes is associated with increased morbidity and mortality. More than one million deaths were attributed to this condition in 2017 alone, ranking it as the ninth leading cause of mortality [4].

The majority of patients fail to achieve good glycemic control levels, the main goal of treatment for all diabetes patients to prevent adverse outcomes. The reasons for poor glycemic control are complex and multi-factorial [5, 6].

In Ethiopia, the blood glucose level of most diabetic patients is shown to be ineffectively controlled. A systemic review and meta-analysis on glycemic control and associated factors among diabetic patients in Ethiopia showed that; the prevalence of poor glycemic control is 65.6%. Residence, dyslipidemia, and diet adherence were associated with poor glycemic control among diabetic patients [7]. Other studies done in Shanan Gibe, Dessie, and Gonder hospitals showed that 59.2%, 70.8%, and 64.7% of diabetic patients had poor glycemic control respectively. Poor adherence to diet and antidiabetic medications, level of education, and duration of diabetic treatment were shown to be associated with poor glycemic control [8, 9, 10].

Most patients with diabetes can avoid the risk of developing complications by improving self–care activities in terms of adherence to diet, medications, physical activity, and blood glucose monitoring. Self-care practices are vital for diabetes management. Therefore, self-care activities should be monitored regularly, especially for patients at risk of poor glycemic control [11, 12, 13]. Little is known about diabetic self-care practice and glycemic control of type 2 diabetes patients in the study area. Therefore, this study aimed to assess diabetic self-care practice and glycemic control status of type 2 diabetes patients on follow-up at Gebre Tsadik Shewa General Hospital, Southwest Ethiopia.

Methods and materials

A hospital-based prospective observational study was conducted among type 2 diabetes patients on follow-up at the diabetic clinic of Gebre Tsadik Shewa General Hospital from February 1 to May 30, 2021. The hospital is found in Bonga Town, Kaffa zone, Southwest Ethiopia. The hospital provides both in-patient and outpatient services. All adult type 2 diabetes patients who fulfill the inclusion criteria were recruited consecutively to the study. All type 2 diabetes patients on follow-up and age greater than 18 years, and patients who consented to participate were included in the study. Patients with type 1 diabetes and patients who were not willing to participate were excluded from the study.

Data collection, procedure, and analysis

Data abstraction checklist and structured questionnaire were developed from a review of literature [14, 15]. A structured questionnaire was used to collect sociodemographic characteristics, self-care practice and behaviors (smoking, alcohol consumption, medication adherence, self-monitoring of blood glucose, adherence to diet, and physical activity). The Summary Diabetes Self-Care Activities (SDSCA) questionnaire was used to assess details about self-care practice of patients [16]. Data abstraction format was used to collect the current medication regimen, the number of medications, laboratory and clinical data (comorbidities, duration of diabetes, complication) from patients’ medical records. The data collection tool was pretested on 7 (5%) of patients at Mizan-Tepi university teaching hospital to check its consistency and clarity before the actual data collection. Epi data version 4.4.6 was used to enter, encode and clear data. Then the data was exported to SPSS version 26 for analysis. Descriptive statistics, such as frequency, proportion, mean, and standard deviation was used to summarize patients’ baseline and clinical characteristics. Binary logistic regression analysis was used to determine factors associated with poor glycemic control. Statistical significance was considered at a p-value <0.05.

Outcome measurement

The primary outcome variables were the level of diabetic self-care practice and status of glycemic control. The average of three fasting blood glucose measurements was used to determine the patient’s glycemic control status.

Definition of terms

Glycemic control was assessed by using fasting blood glucose (FBG) levels. Good glycemic control was defined as the three-month average fasting blood glucose 80–130 mg/dl and poor glycemic control is defined as the three-month average fasting blood glucose>130 mg/dl according to the American diabetic association (ADA) [2]. Knowledge of optimum blood glucose level: Patients’ understanding of optimal or target blood glucose level. Adherence to diet: Patients who reported an average of 4–7 days of information to the questions on diet were classified as having good dietary practice; those reporting less than four days were classified as having poor dietary practice. Adherence to physical activity: Patients who reported at least 30–60 min of moderate aerobic activity per day or 3 days per week. Medication adherence: Patients who took all the prescribed antidiabetic medications during the last 7 days were considered adherent. Self-monitoring of blood glucose (SMBG): Patients who performed SMBG at their respective homes for greater than 3 days in the last 7 days were considered adherent to blood glucose measurement. Co-morbidity: Chronic illnesses that coexisted in patients with type 2 diabetes. Polypharmacy was defined as the use of greater than five medications [17, 18].

Result

Sociodemographic and clinical characteristics of participants

The study included a total of 138 type 2 diabetes patients over four months. More than half, 82(59.4%), of patients were males and 72(52.2%) were in the age 60 years and above. The mean age of patients was 49.35± 11.58 years, range from 30 to 81 years. More than a third, 51(36.9%) were illiterate. The mean (± SD) BMI of patients was 26.24± 3.22. Fifty (36.2%) patients were overweight and 30(21.7%) patients had obesity. The mean (±SD) duration of diabetes was 6.21 ± 4.34 years. Seventy-four (53.6%) patients had a diabetic duration of less than five years. More than half of patients 78(56.5%) reported a history of alcohol consumption and 2(1.4%) reported a history of smoking. Twenty (14.5%) patients had diabetic-related complications. The most common complications were neuropathy,10(7.24%) followed by nephropathy 4(2.89%), retinopathy 2(1.44%), and neuropathy plus nephropathy 4(2.89%). The majority of patients, 83(60.15%) had at least one comorbidity. Hypertension, 43(31.1%), and heart failure, 21(15.2%) were the most common comorbidities (Table 1).

Table 1.

Sociodemographic and clinical characteristics of type 2 diabetes patients

Variables Category Frequency Percent (%)
Sex Male 82 59.4
Female 56 40.6
Age <60 66 47.8
60 72 52.2
Level of educational Illiterate 51 36.9
Primary education 22 15.9
Secondary education 35 25.4
College and above 30 21.7
Alcohol consumption Yes 78 56.5
No 60 43.5
Cigarette smoking Never smoke 126 91.3
Previous smoker 10 7.3
Current smoker 2 1.4
Duration of diabetes 10 years 24 17.4
5–10 years 40 29
<5 years 74 53.6
Diabetic complication Yes 20 14.5
No 118 85.5
BMI (Kg/m2) Healthy weight (18–24) 58 42
Overweight (25–29.9) 50 36.2
Obese (30) 30 21.7
Presence of Comorbidities Yes 83 60.15
No 55 39.85
Type of comorbidities Hypertension 43 31.1
Heart failure 21 15.2
Hypertension +Heart failure 11 7.9
Others 8 5.8

*Others -CKD=3, IHD=3, dyslipidemia=2

Self-care practice and glycemic control of type 2 diabetes patients

Self-care practice and glycemic control status of type 2 diabetes patients is shown in Table 2. Only 30 (21.7%) of the respondents adhered to their general diet recommendations. Almost all patients (98.6%) were not doing adequate physical exercise performed at least 30-60 min per day or 3 days per week during the 7 days preceding the study period. The majority,133 (96.4%), of respondents were not testing their blood glucose level. Seventy-seven (55.8%) respondents were not taking their medication as recommended by their physician. Seventy-one (51.4.0%) of the respondents do not know the optimum blood glucose level for diabetes management. Regarding self-care practice and status of glycemic control, eighty-five (79%) patients with poor diet adherence, 102(75%) patients with inadequate physical activity, 99(74.4%) patients with non-adherence to self-monitoring of blood glucose (SMBG), and 65(84.4%) patients with drug non-adherence had poor level of glycemic control.

Table 2.

Self-care practice and glycemic control of type 2 diabetes patients

Variables Category Glycemic control status Total
n (%)
Poor Good
Diet adherence Good 18 12 30(21.7)
Poor 85 23 108(78.3)
Physical activity Adequate 1 1 2(1.4%)
In adequate 102 34 136(98.6%)
Adherence to SMBG Yes 4 1 5(3.6%)
No 99 34 133(96.4%)
Drug adherence Yes 38 23 61(44.2%)
No 65 12 77(55.8%)
Knowledge of optimal blood sugar Yes 59 12 71(51.4%)
No 44 23 67(48.6%)

Abbreviations SMBG, Self-monitoring of blood glucose

Medication use pattern among type 2 diabetes patients

Out of the 138 patients, oral antidiabetes medications were prescribed to 102(74%) of patients, 60(43.5%) were on metformin and glibenclamide, and 42(30.4%) respondents were taking metformin only. Twenty-two (16%) patients were taking metformin and insulin. Enalapril,34(56%) and Enalapril + HCT,13(21.7%) were most common prescribed concomitant medications. Twenty-six (18.8%) patients were prescribed polypharmacy. Statin and aspirin therapy were initiated for 2.2% and 5.6% of participants, respectively (Table 3).

Table 3.

Medication use pattern among type 2 diabetic patients

Variables Category Frequency Percent (%)
Antidiabetic medications
Insulin alone Yes 14 10
No 124 89.9
Metformin alone Yes 42 30.4
No 96 69.6
Insulin + metformin Yes 22 16
No 116 84.1
Metformin + glibenclamide Yes 60 43.5
No 78 56.5
Concomitant medication Yes 60 43.5
No 78 56.5
Type of concomitant medication Enalapril 34 56.6
Enalapril + HCT 13 21.7
Enalapril + Atenolol 6 10
Others* 7 11.7
Polypharmacy Yes 26 18.8
No 112 81.2
Aspirin therapy Yes 5 3.6
No 133 96.4
Statin therapy Yes 3 2.2
No 135 97.8

Note: *Others-Amlodipine = 4, Metoprolol = 3, HCT-Hydrochlorothiazide

Glycemic control and its associated factors

The mean (±SD) baseline FBS level was 191.44±62.22 mg/dl and the mean (± SD) of three months average FBS was 181.64± 54.42 mg/dl. The average three-month FBS measurement revealed that only 35(25.4%) patients had good glycemic control. The majority of patients, 103(74.6%) had poor glycemic control. The rate of glycemic control was 25.4%. On multivariate logistic regression, BMI (AOR 4.1, CI:1.20–14.11, p = 0.024) and drug adherence (AOR3.08, CI:1.22–7.08, p = 0.017) were factors associated with poor glycemic control (Table 4).

Table 4.

Factors associated with poor glycemic control among type 2 diabetic patients

Univariate logistic regression Multivariate logistic regression
Variables Category OR (95%CI) P-value AOR (95%CI) P-value
Age in years 60 2.5) 1.11–5.63( 0 0.027 0.4(0.16–1.008) 0.052
<60 1 1
Duration of DM in years 10 2.06) 1.07–5.42( 0.14 2.6(0.85–8.23) 0.09
5–10 0.51) 0.18–1.40( 0 0.194 0.5(0.17–1.53) 0.231
<5 1 1
BMI 30 3.06)1.003–9.36( 0.049 4.1(1.20–14.11) 0.024*
25–29 1.170 ) 0.36–3.74( 0.79 1.7(0.49–6.32) 0.381
18–24 1 1
Drug adherence Yes 1 1
No 2.45)1.07–5.61( 0.034 3.08(1.22–7.08) 0.017*
Knowledge of optimal blood sugar Yes 1 1
No 2.57) 1.15–5.71( 0.021 0.4(0.17–1.01) 0.054

Note: *Statistically significance

Abbreviations: BMI, Body mass index, DM, Diabetes Mellitus

Discussion

Diabetes mellitus remained a major public health concern, especially in developing countries. To prevent serious adverse outcomes associated with the disease, patients are required to adhere to diabetic self-care practice, the mainstay of management to maintain good glycemic control. Good self-care management focusing on diet, medication, regular exercise, and self-monitoring of blood glucose is important to maintain optimum blood glucose level and prevent complications results from hyperglycemia. However, poor adherence to self-care practices persists as the main problem of most diabetic patients [19, 20].

In our study; regarding self-care practice, 78.3%, 98.6%, 96.4% of participants had poor adherence to diet, exercise, self-monitoring of blood glucose respectively. Patients’ non-adherence to diet, exercise, and SMBG in our study is higher than findings reported from other studies done in Ethiopia, where the level of non-adherence to diet, exercise, and SMBG were 75.9%, 53.7%, and 83.5% in Addis Ababa and 58.8%, 60.9%, and 59% in Metu respectively [17, 18]. The variation with these studies might be due to differences in the educational status of participants, lack of educational sessions for diabetic patients, and lack of glucometer for self-monitoring of blood glucose in most diabetic patients. Knowledge of diabetes and its disease process, having a glucometer at home, and a high level of education are shown to be positively associated with proper self-care practice and glycemic control of patients [21]. The level of non-adherence to exercise and diet is also higher than results reported from a study done in Nepal, where only 32.4% and 10.1% of participants were shown to have inadequate practice towards exercise and dietary recommendations [19]. In our study, we found that 55.8% of participants didn’t adhere to their anti-diabetic medications. The magnitude of non-adherence to antidiabetic medications in our study is higher than 4.3% reported from a study done in Addis Ababa [18], 8.2% Dire Dawa [21], 39% Tigray region [22], and 54.4% Cameroon [23]. The variation with these studies might be due to the absence of counseling on medication adherence and diabetic educational session. In comparison to this finding, previous studies in Ethiopia showed a high self-reported non-adherence rate, 58.8% southwest Ethiopia [17] and 63.9% Northern Ethiopia [24]. The discrepancy with these studies could be attributed to the difference in sample size and study design (single-center vs. multicenter). In general; regarding self-care practice and glycemic control status, 79%, 75%, 74.4%, and 84.4% of patients with poor adherence to diet, physical activity, SMBG, and prescribed medications respectively, had poor glycemic control.

In our study, we found that nearly three-fourths (74.6%) of patients had poor glycemic control. This proportion is higher than findings from previous studies done in Ethiopia, 64.9% western Ethiopia [6], 68.3% Addis Ababa [25], 59.2% Shanan Gibe [8], and 64.7% Gonder [9]. The result is also higher than results reported from other studies, 69.7% reported from Tanzania(26) and 60.8% reported from Jordan [27]. The reason might be due to the presence of poor adherence to the components (diet, physical activity, SMBG, medications) of self-care practice in our study compared to these studies. Therefore, strategies should be developed to improve the self-care practice of patients. The result is comparable with 72.7% report from a study done in Southwest Ethiopia [17] and 74.9% from a study done in Saudi Arabia [28]. However, this finding is lower than that found from another study in Ethiopia, reported as 81.7% Jimma [29] and 84.3% Uganda [30]. The variation might be due to differences in study design, sample size, and type of diabetic patients included (type 2 only vs. both type 1 and type 2), type of treatment (insulin-treated vs. both insulin and oral antidiabetic medications) in these studies when compared with this study.

Poor adherence to antidiabetic medications is a major problem in the management of patients with diabetes. We found that patients who didn’t adhere to their antidiabetic medications had poor glycemic control(p<0.05) and patients with poor adherence to their medication had significantly high poor glycemic control status than patients with good adherence to medications. Many studies showed non-adherence to antidiabetic medications to be associated with poor glycemic control [26, 31, 32], and other adverse outcomes such as mortality, hospitalizations, complications, and increase in LDL levels [33, 34, 35]. Therefore, educational strategies should be developed and provided to patients with a focus on the impacts of the disease and the importance of adherence to their prescribed medications. Patients’ knowledge about diabetes and higher medication adherence are significant predictors of good glycemic control [36].

In our study, BMI was associated with poor glycemic control. Unlike healthy weight and overweight patients, obese patients had poorly controlled glycemic levels. Similarly, previous studies showed obesity to be associated with poor levels of glycemic control [25, 26, 29, 37]. The reason might be due to the patient’s poor self-care practice such as poor adherence to dietary recommendations and inadequate physical activity. Proper self-care management strategies focusing on diet and exercise should improve patients’ level of glycemic control. Moderate physical activity and adherence to dietary recommendations are shown to be associated with good glycemic control [22].

Conclusions

In conclusion, the findings of the study showed that nearly three-fourths of patients had poor glycemic control and the level of self-care practice was poor. The majority of patients did not adhere to recommended diet, physical activity, antidiabetic medications, and self-monitoring of blood glucose and most of them had poor glycemic control. On multivariate logistic regression drug non-adherence and BMI were found to have a statistically significant association with poor glycemic control. The study emphasized the need to improve awareness of type 2 diabetic patients with education on the importance of self-care practice and glycemic control. This may help to prevent adverse outcomes associated with the disease.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Abbreviations

ADA

American diabetic association

BMI

Body mass index

DM

Diabetic Mellitus

FBS

Fasting blood sugar

IDF

International Diabetic Federation

WHO

World Health Organization

Author contributions

All authors made a significant contribution in the conception, study design, execution, acquisition of data, analysis, and interpretation of the study reported, drafting, and editing of the final manuscript. All authors read and approved the final manuscript. All authors agree to take responsibility and be accountable for the contents of the article.

Funding

Not applicable.

Code availability

Not applicable.

Declarations

Ethical consideration and consent to participate.

Letter of permission was obtained from the school of pharmacy (Reference number 038/2013), and official permission was obtained from the hospital clinical director before data collection begins. The patient’s written informed consent to participate in the study was obtained after a comprehensive explanation of the purpose of the study. Data collection was done anonymously by coding data collection formats using non-identifiable code. The study meets the ethical and scientific standards outlined in national and international guidelines.

Data sharing statement

The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.

Consent for publication

Not applicable

Conflicts of interest/Competing interests

The authors report no competing interests in this work.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Abinet Abebe, Email: abinetabebe.21@gmail.com.

Yohannes Wobie, Email: yohanneswobie@gmail.com.

Bezie Kebede, Email: beza.kebede21@gmail.com.

Alemnew Wale, Email: walealemnew@gmail.com.

Alemnew Destaw, Email: alemrondesta66@gmail.com.

Abyou Seyfu Ambaye, Email: abyou@mtu.edu.et.

References

  • 1.Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 th edition. Diabetes Res Clin Pract. 2019;157:107843. Available from: 10.1016/j.diabres.2019.107843. [DOI] [PubMed]
  • 2.American Diabetic Association. Standards of Medical Care in Diabetes — 2020 Abridged for Primary Care Providers. Clin Diabetes. 2020;38(1):1–29. Available from: 10.2337/cd20-as01. [DOI] [PMC free article] [PubMed]
  • 3.Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193–203. Available from: doi: 10.2337/dc08-9025. Epub 2008 Oct 22. PMID: 18945920; PMCID: PMC2606813. [DOI] [PMC free article] [PubMed]
  • 4.Khan MAB, Hashim MJ, King JK, et al. Epidemiology of Type 2 Diabetes – Global Burden of Disease and Forecasted Trends. J Epidemiol Glob Health. 2020;10(1):107–11. Available from: doi: 10.2991/jegh.k.191028.001; ISSN 2210-6006; eISSN 2210-6014. [DOI] [PMC free article] [PubMed]
  • 5.Wallace TM, Matthews DR. Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. QJ Med. 2000;93(6):369–74. Available from: 10.1093/qjmed/93.6.369. [DOI] [PubMed]
  • 6.Fekadu G, Bula K, Bayisa G, et al. Challenges And Factors Associated With Poor Glycemic Control Among Type 2 Diabetes Mellitus Patients At Nekemte Referral Hospital, Western Ethiopia. J Multidiscip Healthc. 2019;12:963–74. Available from: doi: 10.2147/JMDH.S232691. PMID: 31819470; PMCID: PMC6878927. [DOI] [PMC free article] [PubMed]
  • 7.Gebreyohannes EA, Netere AK, Belachew SA. Glycemic control among diabetic patients in Ethiopia: A systematic review and meta- analysis. PLoS One. 2019;14(8):1–14. Available from: doi: 10.1371/journal.pone.0221790. PMID: 31454396; PMCID: PMC6711596. [DOI] [PMC free article] [PubMed]
  • 8.Yigazu DM, Desse TA. Glycemic control and associated factors among type 2 diabetic patients at Shanan Gibe Hospital, Southwest Ethiopia. BMC Res Notes [Internet]. 2017;10(597):1–6. Available from: doi: 10.1186/s13104-017-2924-y. PMID: 29141693; PMCID: PMC5688756. [DOI] [PMC free article] [PubMed]
  • 9.Abebe SM, Berhane YWA, et al. Level of sustained glycemic control and associated factors among patients with diabetes mellitus in Ethiopia. Diabetes, Metab Syndr Obes Targets Ther. 2015;8:65–71. Available from: 10.2147/DHPS.S68786. [DOI] [PMC free article] [PubMed]
  • 10.Fiseha T, Alemayehu E, Kassahun W, et al. Factors associated with glycemic control among diabetic adult out – patients in Northeast Ethiopia. BMC Res Notes. 2018;11(316):1–6. Available from: 10.1186/s13104-018-3423-5. [DOI] [PMC free article] [PubMed]
  • 11.Ketema DB, Leshargie CT, Kibret GD, et al. Level of self-care practice among diabetic patients in Ethiopia: a systematic review and meta-analysis. BMC Public Health. 2020;20(309):1–12. Available from: 10.1186/s12889-020-8425-2. [DOI] [PMC free article] [PubMed]
  • 12.Bukhsh A, Khan TM, Nawaz MS, et al. Association of diabetes-related self-care activities with glycemic control of patients with type 2 diabetes in Pakistan. Patient Prefer Adherence. 2018;12:2377–85. Available from: 10.2147/DMSO.S209711. [DOI] [PMC free article] [PubMed]
  • 13.Tewahido D, Berhane Y. Self-Care Practices among Diabetes Patients in Addis Ababa: A Qualitative Study. PLoSOne. 2017;12(1):1–10. Available from: 10.1371/journal.pone.0169062. [DOI] [PMC free article] [PubMed]
  • 14.Kassahun T, Gesesew H, Mwanri L, et al. Diabetes related knowledge, self-care behaviours and adherence to medications among diabetic patients in Southwest Ethiopia. BMC Endocr Disord. 2016;16(28):1–11. Available from: 10.1186/s12902-016-0114-x. [DOI] [PMC free article] [PubMed]
  • 15.Dedefo MG, Ejeta BM, Wakjira GB, et al. Self – care practices regarding diabetes among diabetic patients in West Ethiopia. BMC Res Notes. 2019;12(212):1–7. Available from: 10.1186/s13104-019-4258-4. [DOI] [PMC free article] [PubMed]
  • 16.Toobert DJ, Hampson SE, Glasgow RE. The Summary of Diabetes Self-Care: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943–50. Available from: http://diabetesjournals.org/care. [DOI] [PubMed]
  • 17.Sheleme T, Mamo G, Melaku T, et al. Glycemic Control and its Predictors among Adult Diabetic Patients attending Mettu Karl Referral Hospital, Southwest Ethiopia. Diabetes Ther. 2020;11(8):1775–94. Available from: 10.1007/s13300-020-00861-7. [DOI] [PMC free article] [PubMed]
  • 18.Bonger Z, Shiferaw S, Tariku EZ. Adherence to diabetic self-care practices and its associated factors among patients with type 2 diabetes in Addis Ababa, Ethiopia. Patient PreferAdherence.2018;12:963–70.Availablefrom: 10.2147/PPA.S156043. [DOI] [PMC free article] [PubMed]
  • 19.Baral IA, Baral S. Self-care Management among Patients with Type 2 Diabetes Mellitus in Tanahun,Nepal. Arch Community Med Public Heal. 2021;7(1):37–42. Available from: 10.17352/2455-5479.000131.
  • 20.Dagnew B, Demissie GD, Angaw DA. Systematic Review and Meta-Analysis of Good Self-Care Practice among People Living with Type 2 Diabetes Mellitus in Ethiopia: A National Call to Bolster Lifestyle Changes. Evidence-Based Complement Altern Med [Internet]. 2021;1:1–10. Available from: 10.1155/2021/8896896. [DOI] [PMC free article] [PubMed]
  • 21.Getie A, Geda B, Alemayhu T, et al. Self- care practices and associated factors among adult diabetic patients in public hospitals of Dire Dawa administration, Eastern Ethiopia. BMC Public Health. 2020;20(1232):1–8. Available from: 10.1186/s12889-020-09338-5. [DOI] [PMC free article] [PubMed]
  • 22.Fseha B. Glycemic Control and it ’s Associated Factors in Type 2 Diabetic Patients in Suhul Hospital, Northwest Tigray, Ethiopia. J Diabetes Metab [Internet]. 2017;8(3):1–7. Available from: 10.4172/2155-6156.1000729.
  • 23.Aminde LN, Tindong M, Ngwasiri CA, et al. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon. BMC Endocr Disord [Internet]. 2019;19(35):1–9. Available from: 10.1186/s12902-019-0360-9. [DOI] [PMC free article] [PubMed]
  • 24.Araya EM, Gebrezgabiher HA, Tekulu GH, et al. Medication Non-Adherence and Associated Factors Among Diabetic Patients Visiting General Hospitals in the Eastern Zone of Tigrai, Northern Ethiopia. Patient Prefer Adherence [Internet]. 2020;14:2071–2083. Available from: 10.2147/PPA.S278148. [DOI] [PMC free article] [PubMed]
  • 25.Demoz GT, Gebremariam A, Yifter H, et al. Predictors of poor glycemic control among patients with type 2 diabetes on follow – up care at a tertiary healthcare setting in Ethiopia. BMC Res Notes. 2019;12(207):1–7. Available from: 10.1186/s13104-019-4248-6. [DOI] [PMC free article] [PubMed]
  • 26.Kamuhabwa AR, Charles E. Predictors of poor glycemic control in type 2 diabetic patients attending public hospitals in Dar es Salaam. Drug Healthc Patient Saf [Internet]. 2014;6:155–65. Available from: 10.2147/DHPS.S68786. [DOI] [PMC free article] [PubMed]
  • 27.AL-Eitan LN, Nassar AM, Saadeh NA, et al. Evaluation of Glycemic Control, Lifestyle and Clinical Characteristics in Patients with Type 2 Diabetes Treated at King Abdullah University Hospital in Jordan. Can J Diabetes xxx [Internet]. 2016;1–7. Available from: 10.1016/j.jcjd.2016.04.009. [DOI] [PubMed]
  • 28.Alzaheb RA, Altemani AH. The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia. Diabetes, Metab Syndr Obes Targets Ther. 2018;11:15–21. Available from: 10.2147/DMSO.S156214. [DOI] [PMC free article] [PubMed]
  • 29.Angamo MT, Melese BH, Ayen WY. Determinants of Glycemic Control among Insulin Treated Diabetic Patients in Southwest Ethiopia. PLoS One [Internet]. 2013;8(4):1–8. Available from: doi:10.1371/journal.pone.0061759. [DOI] [PMC free article] [PubMed]
  • 30.Patrick NB, Yadesa TM, Muhindo R, et al. Poor Glycemic Control and the Contributing Factors Among Type 2 Diabetes Mellitus Patients Attending Outpatient Diabetes Clinic at Mbarara Regional Referral Hospital, Uganda. Diabetes, Metab Syndr Obes Targets Ther [Internet]. 2021;14:3123–3130. Available from: 10.2147/DMSO.S321310. [DOI] [PMC free article] [PubMed]
  • 31.Olickal JJ, Chinnakali P, Suryanarayana BS, et al. Medication adherence and glycemic control status among people with diabetes seeking care from a tertiary care teaching hospital, south India. Clin Epidemiol Glob Heal [Internet]. 2021;11(100742):1–6. Available from: 10.1016/j.cegh.2021.100742.
  • 32.Mariye T, Bahrey D, Tasew H, et al. Determinants of Poor Glycemic Control among Diabetes Mellitus Patients in Public Hospitals of the Central Zone, Tigray, North Ethiopia. Endocrinol Metab. 2020;4(2:1):1–7. Available from: doi: 10.36648/endocrinology-metabolism.
  • 33.Pladevall M, Williams LK, Potts LA, et al. Clinical Outcomes and Adherence to Medications Measured by Claims Data in Patients With Diabetes. Diabetes Care. 2005;27(12):2800–5. Available from: 10.2337/diacare.27.12.2800. [DOI] [PMC free article] [PubMed]
  • 34.Ho PM, Rumsfeld JS, Masoudi FA, et al. Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes Mellitus. Arch Intern Med. 2006;166(17):1836–41. Available from: 10.1001/archinte.166.17.1836. [DOI] [PubMed]
  • 35.Van Alsten SC, Harris JK. Cost-Related Nonadherence and Mortality in Patients With Chronic Disease:A Multiyear Investigation, National Health Interview Survey, 2000–2014. Prev Chronic Dis 2020 [Internet]. 2020;17(200244):1–10. Available from: 10.5888/pcd17.200244. [DOI] [PMC free article] [PubMed]
  • 36.Al-Qazaz HK, Sulaiman SA, Hassali MA, et al. Diabetes knowledge, medication adherence and glycemic control among patients with type 2 diabetes. Int J Clin Pharm. 2011;33(6):1028–35. Available from: 10.1007/s11096-011-9582-2. [DOI] [PubMed]
  • 37.Mashele TS, Mogale MA, Towobola OA, et al. Central obesity is an independent risk factor of poor glycaemic control at Dr George Mukhari Academic Hospital. South African FamPract.2019;61(1):18–23.Availablefrom: https://doi.org/10. 1080/20786 190. 2018. 1527134.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

Not applicable.


Articles from Journal of Diabetes and Metabolic Disorders are provided here courtesy of Springer

RESOURCES